Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02135068 · ClinicalTrials.gov registry record · Early Phase 1

Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop

A Early Phase 1 study, sponsored by Yale University.

Completed
Registry status
Early Phase 1
Development phase
15
Enrollment target

NCT02135068: Completed Early Phase 1 study, sponsored by Yale University.

NCT02135068 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 15 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02135068, a Early Phase 1 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Early Phase 1
Development phase
15 participants
Enrollment target

Study Summary

This study is designed to look at how snacking during exercise may help prevent low blood sugars while subjects are on the "closed loop artificial pancreas." This system uses a continuous glucose sensor, an insulin pump, and a computer program that automatically determines how much insulin to give based on the sensor glucose level.

Primary Outcome

Difference in the nadir blood glucose levels during exercise between the two study conditions: Closed Loop alone vs. Closed Loop+ snacking.

Interventions

  • DEVICE Medtronic MiniMed Closed Loop (CL) System
  • OTHER Snacking

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2015-01
Est. Completion 2016-12
Phase Early Phase 1
Yale University

1,492 total trials

What the finished NCT02135068 record still lists

NCT02135068 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 2 interventions - of which Medtronic MiniMed Closed Loop (CL) System is the first listed.

NCT02135068 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02135068 about?

NCT02135068 is a clinical study titled "Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop". This study is designed to look at how snacking during exercise may help prevent low blood sugars while subjects are on the "closed loop artificial pancreas." This system uses a continuous glucose sensor, an insulin pump, and a computer program that automatically determines how much insulin to give b...

What is the current status of trial NCT02135068?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2015-01. Estimated completion is 2016-12.

What interventions are being tested in trial NCT02135068?

The interventions under investigation include: Medtronic MiniMed Closed Loop (CL) System (DEVICE), Snacking (OTHER).

Who is sponsoring clinical trial NCT02135068?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02135068's enrollment target sits among peer trials

15 1403rd of 2000 higher than 527 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02135068, the US trial registry maintained by the National Library of Medicine. NCT02135068 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.